Paola Gazzaniga | Ricerc@Sapienza

Publications

Title	Published on	Year
Evolution of Neo-RAS-WT in Circulating Tumor DNA from First-Line to Subsequent Therapies in Metastatic Colorectal Cancer	CANCERS	2025
Early Detection of Disease Progression in Metastatic Cancers: Could CTCs Improve RECIST Criteria?	BIOMEDICINES	2024
Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2024
VI‐RADS followed by Photodynamic Transurethral Resection of Non‐Muscle‐Invasive Bladder Cancer vs White‐Light Conventional and Second‐resection: the ‘CUT‐less’ Randomised Trial Protocol	BJU INTERNATIONAL	2024
Blood Extracellular Vesicles beyond Circulating Tumour Cells: A Valuable Risk Stratification Biomarker in High-Risk Non-Muscle-Invasive Bladder Cancer Patients	BIOMEDICINES	2024
Signet ring cell carcinoma of the urinary bladder presenting with carcinocythemia and skeletal metastasis: A case report	TUMOR DISCOVERY	2024
Exploring the utility of a NGS multigene panel to predict BCG response in patients with non-muscle invasive bladder cancer	ONCOLOGY RESEARCH	2024
Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancer	FRONTIERS IN ONCOLOGY	2023
Prognostic Role of Circulating Tumor Cell Trajectories in Metastatic Colorectal Cancer	CELLS	2023
Is cancer an intelligent species?	CANCER METASTASIS REVIEWS	2023
An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile	JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH	2022
RAS mutation conversion in bevacizumab-treated metastatic colorectal cancer patients: a liquid biopsy based study	CANCERS	2022
Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation	THE ONCOLOGIST	2022
Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study	ONCOTARGET	2022
An Orthotopic Patient-Derived Xenograft (PDX) Model Allows the Analysis of Metastasis-Associated Features in Colorectal Cancer	FRONTIERS IN ONCOLOGY	2022
In vitro cultures of circulating tumor cells: a potential tool to unravel drug sensitivity	CANCER DRUG RESISTANCE	2022
A Fast and Furious Liquid Biopsy Assay to Monitor Targeted Therapy Resistance	inglese	2022
127P {RAS}, {RAF} and {NF}1 oncogenic mutations in {KRAS}-mutated lung adenocarcinoma	ANNALS OF ONCOLOGY	2022
True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature	CANCER LETTERS	2021
Sequential isolation and characterization of single CTCs and large CTC clusters in metastatic colorectal cancer patients	CANCERS	2021

ERC

LS4_12

KET

Life-science technologies & biotechnologies

Interessi di ricerca

Keywords

liquid biopsy

Progetti di Ricerca

Liquid biopsy to predict radiation therapy- induced immune escape in patients with solid tumors
Urinary mutant DNA (mutDNA) as non-invasive biomarker in non-muscle invasive bladder cancer (NMIBC)
Mutational profile of EpCAM negative circulating tumor cells: gold in the waste

Laboratori di ricerca

BIOPSIA LIQUIDA LAB 01